- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Urinary biomarkers predict severe kidney injury in patients hospitalized with COVID-19

In this study published in the American Journal of Kidney Diseases (AJKD), researchers found that two-fold higher levels of neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein, and kidney injurymolecule-1 were associated with increased risk of severe acute kidney injury or death in patients hospitalized with COVID-19.Acute kidney injury (AKI) is a serious complication...
In this study published in the American Journal of Kidney Diseases (AJKD), researchers found that two-fold higher levels of neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein, and kidney injurymolecule-1 were associated with increased risk of severe acute kidney injury or death in patients hospitalized with COVID-19.
Acute kidney injury (AKI) is a serious complication in patients hospitalized with COVID-19. Researchers hypothesized that biomarkers measured in the urine that are more specific for kidney injury and inflammation than serum creatinine may add to the understanding of kidney injury in the setting of COVID-19. They found that certain biomarkers including epidermal growth factor and kidney injury molecule-1, among others, were associated with stage 3 AKI, dialysis, and death up to 60 days in patients hospitalized with COVID-19. These study results suggest that these studied biomarkers may help identify patients at particularly high risk for adverse kidney outcomes.
TITLE: Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19
https://www.ajkd.org/article/S0272-6386(21)00920-3/fulltext#
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email:Â editorial@medicaldialogues.in. Contact no. 011-43720751